Aderans Research Institute, a biomedical group working toward developing an injectable hair cloning therapy, recently released updates from the second phase of its hair multiplication research trials. According to Aderans, the results of the trial (the second step in a proposed series of seven clinical observations) showed “significant hair growth” in over 50% of participants at the one year mark. Essentially, half the research subjects demonstrated new hair growth one year after receiving the injectable hair cloning therapy.
Although this is definitely exciting news and suggests that hair restoration research is continually progressing, there are several factors to consider before scheduling an injection appointment. The press release, whether intentional or not, does not contain certain, objective details: What does “significant hair growth” mean? Are these new hairs resistant to dihydrotestosterone (DHT – the hormone directly responsible for genetic hair loss)? Why were no objective “before and after” images released? What type of results were observed in the 50% of patients who did not see new growth?
Granted, this is a very recent update and Aderans may continue to analyze the information and release more conclusive data in the future, but there is definitely room for further clarification. However, as Dr. Ken Washenik, M.D., Ph.D. – the Executive Vice President of Aderans states, these new findings are likely an important first step and will lead to even greater future prospects. As usual, I highly recommend utilizing proven, effective techniques, like finasteride (Propecia) and minoxidil (Rogaine), for the time being and remaining “cautiously optimistic” toward future treatments.
Click here for the Aderans press release.
Blake – aka Future_HT_Doc
Follow our community on Twitter
Watch hair transplant videos on YouTube